Opioids and myocardial reperfusion injury

Archives des Maladies du Coeur et des Vaisseaux

Volumn 100, Issue 3, 2007, Pages 231-237

  Gross, G J ^b   Peart, J N ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Adenosine; Opioids; Reactive oxygen species; Reperfusion injury

Indexed keywords

CYTOKINE; DYNORPHIN DERIVATIVE; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; MORPHINE; NALOXONE; OPIATE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE;

CARDIOVASCULAR RISK; DRUG MECHANISM; HEART INFARCTION; HEART PROTECTION; HUMAN; NONHUMAN; OSMOTIC STRESS; PATHOGENESIS; REPERFUSION INJURY; REVIEW;

ANALGESICS, OPIOID; ANIMALS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 34247527861     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Sato H, Jordan JE, Zhao ZQ, Sarvotham SS, Vinten-Johansen J. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg 1997;64:1099-107.
2. Yamazaki S, Fujibayashi Y, Rajagopalan RE, Meerbaum S, Corday E. Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog. J Am Coll Cardiol 1986;7:564-72.
3. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 1988;82:920-7.
4. Todd J, Zhao ZQ, Williams MW, Sato H, Van Wylen DG, Vinten-Johansen J. Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 1996;62:1364-72.
5. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003;60:617-25.
6. Zhao ZQ, Corvera JS, Halkos ME. Kerendi et.al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-88.
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
8. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-60.
9. Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol 2006;291:H827-34.
10. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase B inhibition during reperfusion in intact rat nearts. Circ Res 2004;94:960-6.
11. Zhang Y, Wu YX, Hao YB, Dun Y, Yang SP. Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. Life Sci 2001;68:1013-9.
12. Addison PD, Neligan PC, Ashrafpour H et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 2003;285: H1435-3.
13. Borlongan CV, Wang Y, Su TP. Delta opioid peptide (d-ala 2, d-leu 5) enkephalin: linking hibernation and neuroprotection. Front Biosci 2005;9:3392-8.
14. Peart JN, Gross GJ. Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res Cardiol 2004;99:29-37.
15. Romano MA, Seymour EM, Berry JA, McNish RA, Boding SF. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res 2004;118:32-7.
16. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 2002;93:51-75.
17. Barron BA, Jones CE, Caffrey JL. Pericardial repair depresses canine cardiac catecholamines and met-enkephalin. Regul Pept 1995;59:313-20.
18. Eliasson T, Mannheimer C, Waagstein F, et al. Myocardial turnover of endogenous opioids anacalcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology 1998;89:170-7.
19. Howells RD, Kilpatrick DL, Bailey LC, Noe M. Udenfriend S. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 1996;83:1960-3.
20. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 2003;35:709-18.
21. Wang TL, Chang H, Hung CR, Tseng YZ. Morphine preconditioning attenuates neutrophil activation in rat models of myocardialinfarction. Cardiovasc Res1998;40:557-63.
22. Zhang Y, Irwin MG, Wong TM. Remifentanil preconditioning protects against ischemic iniury in the intact rat heart. Anesthesiology 2004;101:918-23.
23. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 2003;285:H1797-818.
24. Fryer RM, Wang Y, Hsu AK, Gross GJ. Essential activation of PKC- in opioid-initiated cardioprotection. Am J Physiol 2001;280:H1346-H1353.
25. ATP channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res 2002;91:186-8.
26. ATP channel. Ann Rev Physiol 2000;62:79-109.
27. ATP channels during metabolic inhibition and recovery. FASEB J 2001;15:2586-94.
28. ATP channels, free radicals and MEK1/2. J Mol Cell Cardiol 2003;35:985-92.
29. ATP channel triggers delayect ischemic preconditioning in rats. Am J Physiol Heart Circ Physiol 2005;288:H445-7.
30. Schultz JJ, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123-37.
31. Lee JW, Joshi S, Chan JS, Wong YH. Differential coupling of μ-, δ- and κ-opioid receptors to Ga16-mediated stimulation of phospholipase C. J Neurochem 1998;70:2203-11.
32. Fryer RM, Schultz JJ, Hsu AK, Gross GJ. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts. Am J Physiol 1998; 275: H2009-H15.
33. Gross RA, Moises HC, Uhler MD, Macdonald RL. Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc Natl Acad Sci USA 1990;87:7025-9
34. North RA, Williams JT, Surprenant A, Christie MJ. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 1987;84:5487-91.
35. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001;296:647-54.
36. Fryer RM, Wang Y, Hsu AK, et al. Dependence of δ-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway. J Pharmacol Exp Ther 2001;299:477-82.
37. 2+ release from an intracellular pool in rat ventricular cardiac myocytes. Circ Res 1992;70:66-81.
38. 2+ pathway in the cardiac-opioid receptor. Am J Physiol 1998;274:C82-7.
39. Wenzlaff H, Stein B, Teschemacher H. Diminution of contractile response by -opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein. Nauyn-Schmiederberg's Arch Pharmacol 1998;358:360-6.
40. Wang TL, Chang H, Hung CR, Tseng YZ. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction. Am J Cardiol 1997;80:1532-5.
41. Wang TL, Chang H, Hung CR, Tseng YZ. Morphine preconditioning attenuates neutrophil activation in rat models of myocardiarinfarction. Cardiovasc Res 1998;40:557-63.
42. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johan sen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-26.
43. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005;100:57-63.
44. Heusch G, Buchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006;101:354-6.
45. Couvreur N, Lucats L, Tissier R, Bize A, Berdeaux A, Ghaleh B. Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits Am J Physiol Heart Circ Physiol 2006; 291: H1345-50.
46. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005;112:2143-8.
47. Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ. Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther 2005;3:1035-45.
48. Kin H, Zatta AJ, Jiang R, et al. Activation of opioid receptors mediates the infarct size reduction by postconditioning. J Mol Cell Cardiol 2005;38:827.
49. Weihrauch D, Krolikowski JG, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS. Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 2005;101:942-9.
50. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005;65:361-7.
51. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004;44:1111-2.